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of HEV71 shows that the strains from all states in Peninsu-
lar Malaysia had several genetic lineages namely genogroups
B3, B4, B5, C1, C2, C3 and C4. Although they were closely
related to the strains that have been circulating and associ-
ated with outbreaks in the Asia Paciﬁc region since 1997,
these strains were not associated with huge outbreak in
Peninsular Malaysia. The nucleotides and amino acids sub-
stitutions were also analyzed. There was about 18—25%
differences in nucleotide sequences between the peninsular
isolates and the prototype BrCr-CA-70. Nevertheless, all the
changes in VP4 region of the isolated strains were synony-
mous substitutions.
doi:10.1016/j.ijid.2008.05.795
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Background: Dengue virus is a mosquito-borne ﬂavivirus
that represents an important emerging infectious disease
and is an international health concern. Currently, there is
no vaccine or effective antiviral drug to prevent or to treat
dengue virus infection. The development of speciﬁc anti-
dengue molecules would be facilitated by the availability of
efﬁcient anti-dengue screening assays, adaptable to high-
throughput format. In this study, we have developed an
immunoﬂuorescence imaging-based platform that detects
dengue virus replication. We used this assay to screen a
structurally diverse collection of pharmacological kinase
inhibitors.
Methods & Results: Small molecule inhibitors of c-Abl
and c-Src kinases exhibited signiﬁcant anti-dengue activity,
suggesting that these kinases play critical roles in dengue
virus biology. Here, we uncovered a unique role of c-Abl
tyrosine kinase harnessed by dengue virus to mediate virus
entry via clathrin endocytosis. The infectivity of dengue
virus was severely reduced in cells pretreated with GNF2
(speciﬁc inhibitor for c-Abl) in a dosage-dependent manner.
Moreover, dengue virus infection also triggered the activa-
tion of c-Abl by inducing phosphorylation of c-Abl Tyr412.
Using immunoﬂuorescence assay and transmission electron
microscopy, dengue virus particles were observed binding
to the surface of the GNF2 pretreated cells but failed to
enter into the cells. These observations were substantiated
in cells transfected with small interfering RNA designed to
inhibit clathrin and c-Abl expression. Virus infection was sig-
niﬁcantly reduced in knockdown cells relative to controls
cells. Furthermore, dengue virus infection was also aborted
in c-Abl −/−, c-Arg −/− and double c-Abl−/−, c-Arg−/−
deﬁcient cell line.
Conclusions: These ﬁndings reveal a novel role for c-Abl
in facilitating the clathrin-mediated endocytosis of dengue
virus into cells and may serve as a drug target for the devel-
opment of effective anti-viral strategies against dengue
virus infection.
doi:10.1016/j.ijid.2008.05.796
46.016
Identifying Host Factors Involved in Mediating Vascular
Permeability During Dengue Virus Infection
S.P. Ong, M.L. Ng, J.J.H. Chu ∗
National University of Singapore, Singapore, Singapore
Background: Dengue virus (DV) is a mosquito-borne virus,
belonging to the family Flaviviridae. This virus causes the
mild form, Dengue fever (DF) or in severe cases, Dengue
Hemorrhagic Fever (DHF) or Dengue Shock Syndrome (DSS)
characterized by increased capillary permeability. Cur-
rently, there is no speciﬁc antiviral treatment available to
treat patients with DV infection. Furthermore, the patho-
genesis of DHF is poorly understood. Hence the aim of this
study is to identify the host factors that may play a role in
the progression of DHF/DSS during DV infection.
Methods: Human Umbilical Vein Endothelial Cells
(HUVEC) was infected with DV2 at a multiplicity of infection
(M. O. I.) 10. At 72 h post infection (h. p. i.), the expression
of different genes speciﬁc to endothelial cell biology was
analyzed using real-time PCR.
Results: Comparing to non-infected controls, host pro-
teins associated with apoptosis such as caspases 1 and 8
were up-regulated in the infected HUVEC. In addition, pro-
inﬂammatory cytokines such as IL-3, IL-7 and IFN- 1 were
also up-regulated in the DV-infected cells. These molecules
may in turn promote the expression of pro-inﬂammatory
adhesionmolecules like ICAM-1, Selectin E and P, as observed
in our results. All these cellular molecules are associated
with cell migration which could play a role in vascular per-
meability. In addition, this group of cells also presented with
down-regulation of platelet derived factor family genes such
as PF4 which may play a role in the aggregation of platelets.
Conclusion: Identiﬁcation of these host proteins allowed
us to investigate further their roles in the pathogenesis of
DHF/DSS which in turn enable us to identify potential ther-
apeutic leads and better clinical management of patients
suffering from/DHF/DSS.
doi:10.1016/j.ijid.2008.05.797
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Background: None of the multivalent dengue vaccines is
close to licensure and commercially available even after sev-
eral decades of dedicated effort. Researchers applied the
conventional approaches to vaccine development, which is
not successful in all serotypes of dengue virus, thus in our
research, we adopted the reverse vaccinology approach to
design B- and T-cell epitope based vaccine in silico using the
genomic and proteomic information. B- and T-cell responses
to dengue viruses are of vital importance in both protective
immunity and pathogenesis and the peptide vaccine includ-
